Current Control and Future Risk in Asthma Management

Despite international and national guidelines, poor asthma control remains an issue. Asthma exacerbations are costly to both the individual, and the healthcare provider. Improvements in our understanding of the therapeutic benefit of asthma therapies suggest that, in general, while long-acting bronc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, Erika J, Price, David, Haughney, John, Ryan, Dermot, Thomas, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178819/
https://www.ncbi.nlm.nih.gov/pubmed/21966601
http://dx.doi.org/10.4168/aair.2011.3.4.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178819/
https://www.ncbi.nlm.nih.gov/pubmed/21966601
http://dx.doi.org/10.4168/aair.2011.3.4.217

Ejemplares similares